Depressive disorder and antidepressants from an epigenetic point of view

doi:10.5498/wjp.v12.i9.1150

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3858)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

360

WORD

HTML

2545

Figures (1-2)

102

Tables (1-5)

162

Sum=3239

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

269

Download

350

Sum=619

Sep 19, 2022 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Psychiatry. Sep 19, 2022; 12(9): 1150-1168
Published online Sep 19, 2022. doi: 10.5498/wjp.v12.i9.1150

Full Size Figure Download Figure

Figure 2 Epigenetic mechanisms. Epigenetic mechanisms include DNA methylation, noncoding RNA activity (such as microRNA), and posttranslational histone tail modifications. Ac: Histone acetylation; Me: Histone methylation; mRNA: Messenger RNA.

Citation: Šalamon Arčan I, Kouter K, Videtič Paska A. Depressive disorder and antidepressants from an epigenetic point of view. World J Psychiatry 2022; 12(9): 1150-1168
URL: https://www.wjgnet.com/2220-3206/full/v12/i9/1150.htm
DOI: https://dx.doi.org/10.5498/wjp.v12.i9.1150